Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Biomx Ltd.

Floor 5, 22 Einstein Str, 7414003

About the sponsor

Cystic fibrosis is the main therapeutic area in the sponsor’s clinical research, with a focus on chronic lung complications and infection-related disease burden.

  • Pulmonary infection
  • Chronic airway disease
  • Respiratory microbiology

The clinical program centers on respiratory outcomes in people living with cystic fibrosis, particularly conditions affecting the lungs and persistent infection.

About Specializations

Biomx Ltd. runs clinical trials in conditions such as Cystic fibrosis respiratory infection suppression, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Cystic fibrosis respiratory infection suppression

Not recruiting

Study of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:IHMA-2121771-1
  • Sponsor:Biomx Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.